Jo Viney

Jo Viney

Company: Pandion Therapeutics

Job title: Co-Founder, President & CSO

Seminars:

Panel Discussion: Exploring Key Questions to Advance Understanding of Treg Behaviour 11:00 am

Highlighting the importance of exploring the relevant mechanisms of action to further understanding of Treg cell biology and behaviour Exploring the importance of the origin of the Treg cells and viability of the starting material What are the different small molecules or antibodies we can use to target T regs for enhanced immune tolerance?Read more

day: Day One

PT101, an IL-2 Mutein for Selectively Activating & Expanding Treg 3:00 pm

Discovery of PT101, an IL-2 mutein Selective activation and expansion of Tregs Translation of model systems to human studiesRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.